NasdaqGM:AXSMPharmaceuticals
Axsome Therapeutics (AXSM) After Mixed Earnings What Does The Valuation Narrative Say
Axsome Therapeutics earnings spark fresh look at the stock
Axsome Therapeutics (AXSM) shares are back in focus after the company reported second quarter 2026 results on 10 August. Revenue for the period and first half increased, while net losses also widened.
See our latest analysis for Axsome Therapeutics.
Following the earnings release, Axsome Therapeutics shares have eased over the past month, with a 30 day share price return of 7.1% and a 7 day share price return of 3.3%. However, the...